ES535391A0 - Procedimiento para la preparacion de derivados esteroidales - Google Patents

Procedimiento para la preparacion de derivados esteroidales

Info

Publication number
ES535391A0
ES535391A0 ES535391A ES535391A ES535391A0 ES 535391 A0 ES535391 A0 ES 535391A0 ES 535391 A ES535391 A ES 535391A ES 535391 A ES535391 A ES 535391A ES 535391 A0 ES535391 A0 ES 535391A0
Authority
ES
Spain
Prior art keywords
procedure
preparation
steroidal derivatives
steroidal
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES535391A
Other languages
English (en)
Other versions
ES8602844A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES8602844A1 publication Critical patent/ES8602844A1/es
Publication of ES535391A0 publication Critical patent/ES535391A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES535391A 1983-08-25 1984-08-24 Procedimiento para la preparacion de derivados esteroidales Granted ES535391A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH464483 1983-08-25

Publications (2)

Publication Number Publication Date
ES8602844A1 ES8602844A1 (es) 1985-12-01
ES535391A0 true ES535391A0 (es) 1985-12-01

Family

ID=4279973

Family Applications (2)

Application Number Title Priority Date Filing Date
ES535391A Granted ES535391A0 (es) 1983-08-25 1984-08-24 Procedimiento para la preparacion de derivados esteroidales
ES543646A Expired ES8606879A1 (es) 1983-08-25 1985-05-30 Un procedimiento para la preparacion de derivados esteroida-les

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES543646A Expired ES8606879A1 (es) 1983-08-25 1985-05-30 Un procedimiento para la preparacion de derivados esteroida-les

Country Status (21)

Country Link
US (1) US4680290A (es)
EP (1) EP0135762B1 (es)
JP (1) JPS6061595A (es)
KR (1) KR850001767A (es)
AR (1) AR240834A1 (es)
AT (1) ATE37883T1 (es)
AU (1) AU574706B2 (es)
CA (1) CA1252778A (es)
DE (1) DE3474552D1 (es)
DK (1) DK347584A (es)
ES (2) ES535391A0 (es)
FI (1) FI842830A7 (es)
GR (1) GR80196B (es)
HU (1) HU189929B (es)
IL (1) IL72725A (es)
MC (1) MC1618A1 (es)
NO (1) NO161679C (es)
NZ (1) NZ209275A (es)
PH (1) PH19849A (es)
PT (1) PT79130B (es)
ZA (1) ZA846430B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1241947A (en) * 1985-05-31 1988-09-13 Pierre R. Proulx Conjugated polyene sterol derivatives as membrane probes
US4946834A (en) * 1988-12-23 1990-08-07 Smithkline Beecham Corporation Phosphonic acid substituted steroids as steroid 5α-reductase inhibitors
US5026882A (en) * 1988-12-23 1991-06-25 Smithkline Beecham Corporation Phosphinic acid substituted steroids as inhibitors of steroid 5α-reductase
CA2028759A1 (en) * 1989-11-22 1991-05-23 Jean-Marie Cassal Steroids
US5215972A (en) * 1989-11-22 1993-06-01 Hoffmann-La Roche Inc. Steroids
US5244887A (en) * 1992-02-14 1993-09-14 Straub Carl D Stanols to reduce cholesterol absorption from foods and methods of preparation and use thereof
HUT77514A (hu) * 1994-11-30 1998-05-28 Amur Research Corp. Gyógyszerhatóanyagok foszfokolinszármazékai
US5958901A (en) * 1995-06-07 1999-09-28 Genta Incorporated Phosphonic acid-based cationic lipids
EP0830368A1 (en) 1995-06-07 1998-03-25 Genta Incorporated Novel carbamate-based cationic lipids
EP0948341A4 (en) * 1996-09-17 2003-05-21 Supergen Inc DERIVATIVES OF PHOSPHOLIPIDE MEDICINES
US5830432A (en) * 1997-03-31 1998-11-03 Amur Pharmacuticals, Inc. Phospholipid drug derivatives
ES2347027T3 (es) 1998-05-22 2010-10-22 The Board Of Trustees Of The Leland Stanford Junior University Moleculas bifuncionales y terapias basadas en las mismas.
CN1396908A (zh) 2000-01-28 2003-02-12 宝洁公司 美味的精氨酸化合物及其用于心血管健康的应用
US20030045473A1 (en) * 2002-07-19 2003-03-06 Sarama Robert Joseph Compositions, kits, and methods for cardiovascular health
EP2671507A3 (en) 2005-04-28 2014-02-19 Proteus Digital Health, Inc. Pharma-informatics system
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
CN101600429A (zh) * 2006-12-08 2009-12-09 哈多技术有限公司 治疗和预防传染性疾病的胆固醇胺
CA2752373C (en) 2009-02-20 2017-10-10 To-Bbb Holding B.V. Glutathione-based drug delivery system
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20250135007A1 (en) * 2021-12-20 2025-05-01 Ron Weiss Compositions comprising sterol-amino-phosphate compounds and methods of making and use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3248408A (en) * 1963-07-22 1966-04-26 Merck & Co Inc Purification of steroid phosphates

Also Published As

Publication number Publication date
US4680290A (en) 1987-07-14
IL72725A (en) 1988-07-31
AR240834A2 (es) 1991-02-28
NO161679C (no) 1989-09-13
DK347584A (da) 1985-02-26
NZ209275A (en) 1987-06-30
ES8602844A1 (es) 1985-12-01
FI842830A7 (fi) 1985-02-26
MC1618A1 (fr) 1985-07-18
JPS6061595A (ja) 1985-04-09
IL72725A0 (en) 1984-11-30
HUT34997A (en) 1985-05-28
PT79130A (en) 1984-09-01
PT79130B (en) 1986-11-14
KR850001767A (ko) 1985-04-01
NO161679B (no) 1989-06-05
ATE37883T1 (de) 1988-10-15
ES8606879A1 (es) 1986-05-01
CA1252778A (en) 1989-04-18
ZA846430B (en) 1985-04-24
NO843406L (no) 1985-02-26
DE3474552D1 (en) 1988-11-17
AR240834A1 (es) 1991-02-28
HU189929B (en) 1986-08-28
EP0135762A2 (de) 1985-04-03
DK347584D0 (da) 1984-07-13
GR80196B (en) 1985-01-02
AU3222584A (en) 1985-02-28
EP0135762A3 (en) 1986-01-22
PH19849A (en) 1986-07-22
ES543646A0 (es) 1986-05-01
FI842830A0 (fi) 1984-07-13
EP0135762B1 (de) 1988-10-12
AU574706B2 (en) 1988-07-14

Similar Documents

Publication Publication Date Title
ES537830A0 (es) Procedimiento para la obtencion de derivados de 5-amino-4-hidroxivalerilo sustituidos
ES533260A0 (es) Procedimiento para la preparacion de 13a-alquilgonanos
ES546484A0 (es) Procedimiento para la preparacion de derivados de furazano
ES544286A0 (es) Procedimiento para la preparacion de nuevos derivados tiazo-lidinicos
ES535391A0 (es) Procedimiento para la preparacion de derivados esteroidales
ES538621A0 (es) Procedimiento para la preparacion de fenolsulfonftaleinil-b-d-galactosidos
ES524997A0 (es) Procedimiento para la preparacion de derivados de la desoxiuridina
ES545153A0 (es) Procedimiento para la preparacion de n-piridilindoles
MX159669A (es) Procedimiento para la preparacion de derivados de acilamida
ES533624A0 (es) Procedimiento para la preparacion de derivados de tiazolidina
ES524796A0 (es) Procedimiento de preparacion de nuevos derivos de amino-14 esteroides
MX156242A (es) Procedimiento para la preparacion de eter-sulfonatos
ES532957A0 (es) Procedimiento para la preparacion de sulfonilureas substituidas
ES533497A0 (es) Procedimiento para la preparacion de nuevos derivados de 3-fenil-4-cianopirrol
ES535704A0 (es) Procedimiento para la obtencion de derivados de piridinio
ES536306A0 (es) Procedimiento para la preparacion de derivados de quinazolina
ES535185A0 (es) Procedimiento para la preparacion de nuevas oxadiacinas
ES546908A0 (es) Procedimiento para la preparacion de derivados de fenilace- tonitrilo
ES528114A0 (es) Procedimiento para la preparacion de hexanorbrassinolid-22-eteres
ES534338A0 (es) Procedimiento para la preparacion de derivados de acridanona
ES525034A0 (es) Procedimiento para la preparacion de derivados de 28-metil-brassinolidas
ES534479A0 (es) Procedimiento para la preparacion de derivados de propan-2-ol
ES531024A0 (es) Procedimiento para la preparacion de aminonitrilos
ES525035A0 (es) Procedimiento para la preparacion de derivados de brassinoesteroides
ES538833A0 (es) Procedimiento para la obtencion de derivados de iminometilazolilo